Vimarsana
Biggest News Aggregation in the World

Page 10 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

The founder of startup Bonobos hid a bipolar diagnosis for decades. Now he's on a mission to destigmatize mental health at work - Vimarsana News

The founder of startup Bonobos hid a bipolar diagnosis for decades. Now he's on a mission to destigmatize mental health at work

Speaking to Fortune Andy Dunn highlighted the power of personal disclosure as a leadership strategy.

Give biotech a chance for the planet's sake, EU lawmakers urged - Vimarsana News

Give biotech a chance for the planet's sake, EU lawmakers urged

European Union lawmakers are being urged to avoid too much risk aversion from holding back the potential of the homegrown biotech sector. Beyond huge promise in healthcare, innovative, low carbon applications in areas like agriculture and food systems and energy production could help address pressing environmental and sustainability challenges.

Source: yahoo.com
Bon Vivant Raises $15.8M in Seed Funding - Vimarsana News

Bon Vivant Raises $15.8M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Bon Vivant eyes cow-free dairy protein scale-up after raising $15.9m - Vimarsana News

Bon Vivant eyes cow-free dairy protein scale-up after raising $15.9m

The French biotech company reportedly closed an ‘oversubscribed’ round of equity financing that would enable the firm to ramp up the production of dairy-identical proteins.

Bon Vivant toasts taking $15.9M to brew up versatile animal-free dairy proteins - Vimarsana News

Bon Vivant toasts taking $15.9M to brew up versatile animal-free dairy proteins

Lyon, France-based precision fermentation startup Bon Vivant, which is using biotech techniques to reprogram yeast microorganisms to produce animal-free milk proteins with a substantially lower environmental footprint than traditional dairy, credits clarity of strategy and execution for keeping its investors enthused at a time when raising remains a challenge for many tech founders. All the investors in its April 2022 pre-seed (€4M) followed on for the oversubscribed €15M (~$15.9M) seed it's announcing today, according to CEO and co-founder, Stéphane MacMillan. The ro...

Source: yahoo.com